CDC, the U.S. Food and Drug Administration (FDA), state and local health departments, and other clinical and public health partners are investigating a multistate outbreak of lung injury associated with e-cigarette product (devices, liquids, refill pods, and/or cartridges) use.
Here is some up to date information released by the CDC as of September 24th.
There have been 805 cases of lung injury reported from 46 states and 1 U.S. territory. Twelve deaths have been confirmed in 10 states.
CDC has received complete sex and age data on 373 cases.
Nearly three fourths (72%) of cases are male
Two thirds (67%) of cases are 18 to 34 years old
16% of cases are under 18 years
38% of cases are in people under 21 years
17% are 35 years or older
All reported cases have a history of e-cigarette product use or vaping.
Based on initial data from certain states we know: Most patients have reported a history of using e-cigarette products containing THC. Many patients have reported using THC and nicotine. Some have reported the use of e-cigarette products containing only nicotine.
As of September 24, 2019 at 5pm, 805* cases of lung injury associated with the use of e-cigarette or vaping products have been reported to CDC from the following states and 1 U.S. territory: AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, ME, MD, MI, MN, MO, MT, MS, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, and USVI. These numbers may change frequently.
CDC has received complete sex and age data on 373 cases.
Nearly three fourths (72%) of cases are male
Two thirds (67%) of cases are 18 to 34 years old
16% of cases are under 18 years
38% of cases are in people under 21 years
17% are 35 years or older
Twelve deaths have been confirmed in California (2), Florida, Georgia, Illinois, Indiana, Kansas (2), Minnesota, Mississippi, Missouri, and Oregon.
All patients have a reported history of e-cigarette product use, and no consistent evidence of an infectious cause has been discovered. Therefore, the suspected cause is a chemical exposure.
Based on initial data from certain states we know: Most patients have reported a history of using e-cigarette products containing THC. Many patients have reported using THC and nicotine. Some have reported the use of e-cigarette products containing only nicotine.
No consistent e-cigarette or vaping product, substance, or additive has been identified in all cases, nor has any one product or substance been conclusively linked to lung disease in patients.
